Bilaketaren emaitzak - Marieke Pierik

Findu emaitzak
  1. 1
    Probiotics in the Management of Inflammatory Bowel Disease

    Probiotics in the Management of Inflammatory Bowel Disease nork Daisy Jonkers, John Penders, Ad Masclee, Marieke Pierik

    Argitaratua 2012
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease

    Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease nork Pan Xu, Montserrat Elizalde, Ad Masclee, Marieke Pierik, Daisy Jonkers

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Prevalence of Self-Reported Spondyloarthritis Features in a Cohort of Patients with Inflammatory Bowel Disease

    Prevalence of Self-Reported Spondyloarthritis Features in a Cohort of Patients with Inflammatory Bowel Disease nork C. Stolwijk, Marieke Pierik, Robert Landewé, Ad Masclee, Astrid van Tubergen

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease nork Liesbet Henckaerts, Marieke Pierik, Marie Joossens, Marc Ferrante, P. Rutgeerts, Séverine Vermeire

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation

    Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation nork Edgar S. Wills, Daisy Jonkers, Paul H. M. Savelkoul, Ad Masclee, Marieke Pierik, John Penders

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease

    Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease nork Corinne Spooren, Marieke Pierik, Maurice P. Zeegers, Edith J. M. Feskens, A.A.M. Masclee, Daisy Jonkers

    Argitaratua 2013
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model

    Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model nork Pan Xu, Elhaseen Elamin, Montserrat Elizalde, Paul P. H. A. Bours, Marieke Pierik, Ad Masclee, Daisy Jonkers

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects

    The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects nork Danyta I. Tedjo, Daisy Jonkers, Paul H. M. Savelkoul, Ad Masclee, Niels van Best, Marieke Pierik, John Penders

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Treatment of Crohn’s disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study

    Treatment of Crohn’s disease-related high perianal fistulas combining the mucosa advancement flap with platelet-rich plasma: a pilot study nork K. W. A. Göttgens, R.R. Smeets, Laurents P. S. Stassen, Geerard L. Beets, Marieke Pierik, Stéphanie O. Breukink

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    High risk of drug‐induced microscopic colitis with concomitant use of <scp>NSAID</scp>s and proton pump inhibitors

    High risk of drug‐induced microscopic colitis with concomitant use of <scp>NSAID</scp>s and proton pump inhibitors nork Bas Verhaegh, Frank de Vries, Ad Masclee, Ali Keshavarzian, Anthonius de Boer, Patrick C. Souverein, Marieke Pierik, Daisy Jonkers

    Argitaratua 2016
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

    High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy nork Zuzana Zelinková, Colin de Haar, Lissy de Ridder, Marieke Pierik, E.J. Kuipers, Maikel P. Peppelenbosch, C. Janneke van der Woude

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    The fecal microbiota as a biomarker for disease activity in Crohn’s disease

    The fecal microbiota as a biomarker for disease activity in Crohn’s disease nork Danyta I. Tedjo, Agnieszka Smolinska, Paul H. M. Savelkoul, Ad Masclee, Frederik‐Jan van Schooten, Marieke Pierik, John Penders, Daisy Jonkers

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age—An Increasing Distinct Entity?

    Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age—An Increasing Distinct Entity? nork Steven Jeuring, Tim van den Heuvel, Maurice P. Zeegers, Wim H. Hameeteman, Mariëlle Romberg‐Camps, Liekele E. Oostenbrug, Ad Masclee, Daisy Jonkers, Marieke Pierik

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis

    Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis nork Bernard Flourié, Hervé Hagège, Gilbert Tucat, D Maetz, Xavier Hébuterne, Johan P. Kuyvenhoven, T. G. Tan, Marieke Pierik, Ad Masclee, Olivier Dewit, C Probert, D. Aoucheta

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients

    Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients nork Marlijne C. G. de Graaf, Corinne Spooren, E M B Hendrix, M. Hesselink, Edith J. M. Feskens, Agnieszka Smolinska, Dániel Keszthelyi, Marieke Pierik, Zlatan Mujagic, Daisy Jonkers

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission

    Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission nork Arta Aliu, Daan H. C. A. Bosch, Dániel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean‐Frédéric Colombel, Rachel Sawyer, Hans Törnblom, Ailsa Hart, Daisy Jonkers, Marieke Pierik, Zlatan Mujagic

    Argitaratua 2024
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort

    Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort... nork Steven Jeuring, Tim van den Heuvel, Limmie Y.L. Liu, Maurice P. Zeegers, Wim H. Hameeteman, Mariëlle Romberg‐Camps, Liekele E. Oostenbrug, Ad Masclee, Daisy Jonkers, Marieke Pierik

    Argitaratua 2016
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort—Can Diagnostic Factors Explain the Increase in IBD Incidence?

    A 20-Year Temporal Change Analysis in Incidence, Presenting Phenotype and Mortality, in the Dutch IBDSL Cohort—Can Diagnostic Factors Explain the Increase in IBD Incidence? nork Tim van den Heuvel, Steven Jeuring, Maurice P. Zeegers, Dorien H.E. van Dongen, Anouk Wolters, Ad Masclee, Wim H. Hameeteman, Mariëlle Romberg‐Camps, Liekele E. Oostenbrug, Marieke Pierik, Daisy Jonkers

    Argitaratua 2017
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

    Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (A... nork Pieter Dewint, Bettina E. Hansen, Elke Verhey, Bas Oldenburg, Daniël W. Hommes, Marieke Pierik, Cyriel Ponsioen, Hendrik M. van Dullemen, Maurice G. Rüssel, Ad A. van Bodegraven, C. Janneke van der Woude

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease

    Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease nork Erwin Dreesen, Filip Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Édouard Louis, Bas Oldenburg, Benjamin Pariente, Marieke Pierik, C. Janneke van der Woude, Geert D’Haens, Séverine Vermeire, Ann Gils

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: